This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Prognosis

Authoring team

  • depends on the underlying cause
  • outcomes are more favourable for those with hyposmia rather than anosmia
  • if there is a specific identifiable trigger e.g. medication induced olfactory disturbance, then then cessation of that trigger often leads to symptomatic resolution
  • traumatic anosmia
    • about 30% of patients with traumatic olfactory dysfunction will resolve ( majority within 12 weeks)
  • post-viral anosmia
    • estimated to resolve in 35%-65% if cases
    • COVID-19-related anosmia significantly improves within 4 weeks in 90% of cases

Reference:

  • Deutsch PG et al. Anosmia: an evidence-based approach to diagnosis and management in primary care British Journal of General Practice 2021; 71: 135-138. DOI: https://doi.org/10.3399/bjgp21X715181
  • Boesveldt S et al. Anosmia- A Clinical Review Chem Senses. 2017 Sep; 42(7): 513–523.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.